Development of BBB-penetrating Peptide, DNP2, Based CTLA-4 Drug Candidate for Inducing Regulatory T Cells in Multiple Sclerosis
Opportunity ContactJames Noh, CEOSeoul, South Korea Hanyang University Website Pharmalicensing.com We identify a cell-permeable peptide, dNP2, which efficiently delivers proteins into mouse and human T cells, as well as various tissues. Introduction/BackgroundWe